Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus.
Anterior nares cultures from 664 hospital personnel identified 165 (24.8%) as carriers of Staphylococcus aureus. Persistent carriers (17.8%) were identified and randomly assigned to one of four treatment groups: rifampin (600 mg once a day for 5 days), bacitracin ointment (topically applied three ti...
Guardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1984
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185544/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6732212/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.4.422 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|